ALPS Medical Breakthroughs ETF Rating $32.68 +0.08 (+0.25%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.92Holdings in SBIO have an aggregate rating of Moderate Buy based on 458 analyst ratings issued in the past year covering 50 companies (86.8% of the portfolio).SBIO Aggregate Price Target$32.68High Prediction$32.68Average Prediction$32.68Low Prediction$32.68Holdings in SBIO have an aggregate price target of $32.68 and a range of $32.68 to $32.68 covering 50 companies (86.8% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy29 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.96%AXSMAxsome Therapeutics$137.75+6.7%4.5314 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage4.55%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%114.17%VRNAVerona Pharma$67.96+5.9%1.9177 of 5 stars3.13$57.14 -15.9%83.08%PTCTPTC Therapeutics$50.69+0.6%3.62 of 5 stars2.47$58.85 16.1%15Analyst ForecastNews Coverage3.08%RNAAvidity Biosciences$31.12-4.3%1.6172 of 5 stars3.00$65.80 111.4%102.81%RYTMRhythm Pharmaceuticals$56.07-2.9%4.0825 of 5 stars2.91$68.09 21.4%11Analyst ForecastInsider TradeNews Coverage2.80%AKROAkero Therapeutics$51.84+2.5%4.4064 of 5 stars3.00$75.86 46.3%9Insider Trade2.71%CRNXCrinetics Pharmaceuticals$37.48+1.7%3.9214 of 5 stars2.92$72.64 93.8%132.69%ZLABZai Lab$33.78+9.0%2.5888 of 5 stars3.33$55.00 62.8%3Upcoming EarningsAnalyst RevisionNews CoverageGap UpHigh Trading Volume2.68%ACADACADIA Pharmaceuticals$19.95-1.7%2.5793 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓2.59%MRUSMerus$47.37-0.5%2.9171 of 5 stars3.13$85.92 81.4%162.46%DNLIDenali Therapeutics$20.75-3.9%4.44 of 5 stars2.93$37.42 80.3%152.38%XENEXenon Pharmaceuticals$39.73+0.9%2.7138 of 5 stars3.11$57.38 44.4%9Options VolumeNews Coverage2.15%FOLDAmicus Therapeutics$9.19+1.3%4.187 of 5 stars2.78$16.75 82.3%9Analyst DowngradeNews Coverage2.13%VCELVericel$52.00-4.3%2.9448 of 5 stars3.00$63.14 21.4%7Positive News2.11%MLTXMoonLake Immunotherapeutics$42.28+0.4%2.0676 of 5 stars3.00$85.50 102.2%8News Coverage2.03%EWTXEdgewise Therapeutics$27.07-0.1%1.6533 of 5 stars2.86$41.29 52.5%72.02%MIRMMirum Pharmaceuticals$52.50-1.2%2.6731 of 5 stars3.09$57.10 8.8%11News Coverage1.82%PTGXProtagonist Therapeutics$38.75+0.7%3.8064 of 5 stars3.00$56.00 44.5%9Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up1.54%BCRXBioCryst Pharmaceuticals$9.21-1.9%3.9299 of 5 stars2.83$15.50 68.3%61.53%AGIOAgios Pharmaceuticals$35.22+4.3%4.3488 of 5 stars2.50$56.33 60.0%8Earnings ReportShort Interest ↓1.51%CGONCG Oncology$27.85-1.3%1.8313 of 5 stars3.11$65.14 133.9%9News CoveragePositive News1.49%IDYAIDEAYA Biosciences$21.75+0.1%3.8397 of 5 stars2.93$53.58 146.4%15Gap Up1.49%VERAVera Therapeutics$28.58-3.5%2.261 of 5 stars3.20$65.44 129.0%101.48%TARSTarsus Pharmaceuticals$47.84-1.8%1.1765 of 5 stars3.00$56.00 17.1%7Gap Up1.40%GLPGGalapagos$26.74+0.0%0.2328 of 5 stars1.44$26.75 0.0%91.39%NAMSNewAmsterdam Pharma$18.57-2.3%3.2873 of 5 stars3.00$41.60 124.0%6Upcoming Earnings1.28%IRONDisc Medicine$54.52+0.3%1.8805 of 5 stars3.10$88.90 63.1%10Insider TradeNews Coverage1.24%MNKDMannKind$5.77+1.9%3.0562 of 5 stars3.13$9.21 59.8%81.21%APGEApogee Therapeutics$34.55+1.8%2.2495 of 5 stars3.00$89.71 159.7%71.19%CLDXCelldex Therapeutics$22.46-0.6%1.3287 of 5 stars2.89$60.22 168.1%91.19%IMCRImmunocore$29.92+0.2%1.4211 of 5 stars2.54$65.64 119.4%131.18%PRAXPraxis Precision Medicines$74.49-6.3%1.9375 of 5 stars2.90$145.20 94.9%101.11%LQDALiquidia$16.11-2.4%2.0541 of 5 stars3.11$25.38 57.5%91.07%VIRVir Biotechnology$9.57-2.3%3.3248 of 5 stars2.83$34.83 264.0%6Insider Trade1.06%GPCRStructure Therapeutics$23.70+1.3%2.4974 of 5 stars3.00$81.29 243.1%81.04%VRDNViridian Therapeutics$16.27-2.1%2.865 of 5 stars2.75$35.70 119.4%121.01%NVAXNovavax$7.99+0.9%3.9838 of 5 stars2.33$17.83 123.2%6Analyst RevisionNews CoverageHigh Trading Volume0.99%NTLAIntellia Therapeutics$12.17-0.7%4.3943 of 5 stars2.72$48.71 300.2%18News CoverageGap Up0.98%DAWNDay One Biopharmaceuticals$12.43+1.6%2.1039 of 5 stars3.00$35.71 187.3%9Upcoming EarningsInsider TradeNews Coverage0.89%AUPHAurinia Pharmaceuticals$7.93+1.2%2.5501 of 5 stars3.00$11.50 45.1%2Analyst DowngradeNews Coverage0.88%XNCRXencor$15.74-0.3%3.4776 of 5 stars3.13$34.88 121.6%80.85%REPLReplimune Group$13.98-2.3%4.0934 of 5 stars3.13$19.29 38.0%8Gap Up0.78%RCUSArcus Biosciences$11.06+3.0%2.6026 of 5 stars2.90$29.50 166.7%10Analyst ForecastAnalyst RevisionNews Coverage0.73%AVBPArriVent BioPharma$27.07-1.2%1.1859 of 5 stars3.00$38.00 40.4%40.71%PHVSPharvaris$16.49-0.1%2.2253 of 5 stars3.00$40.50 145.6%4Positive News0.65%PRTAProthena$15.56+2.0%3.3108 of 5 stars2.71$45.83 194.6%7Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume0.61%NUVBNuvation Bio$2.21-2.9%2.0493 of 5 stars3.00$8.20 271.9%50.58%AVXLAnavex Life Sciences$8.35-3.8%3.7939 of 5 stars3.33$44.00 426.9%3Analyst ForecastAnalyst Revision0.56%DNTHDianthus Therapeutics$23.67-0.1%1.7612 of 5 stars3.22$46.83 97.9%9 This page (NYSEARCA:SBIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts